Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

APPROVED_FOR_MARKETING

Conditions studied: HIV Infections

In brief

This study was designed to provide early access to and evaluate the safety of TPV/r in PI-experienced patients with HIV-1 infection.

Key facts

Study ID: NCT00097799
Run by: Boehringer Ingelheim
Starts: 2004-12-01
Last updated by the study team: 2016-11-30

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

1182.70.092 — Fresno, California, United States
1182.70.057 — Glendale, California, United States
1182.70.064 — Harbor City, California, United States
1182.70.079 — Long Beach, California, United States
1182.70.015 — Los Angeles, California, United States
1182.70.053 — Los Angeles, California, United States
1182.70.066 — Los Angeles, California, United States
1182.70.071 — Los Angeles, California, United States
1182.70.137 — Los Angeles, California, United States
1182.70.198 — Los Angeles, California, United States
1182.70.008 — Newport Beach, California, United States
1182.70.081 — Oakland, California, United States
1182.70.095 — Oakland, California, United States
1182.70.067 — Panorama City, California, United States
1182.70.033 — San Diego, California, United States
1182.70.014 — San Francisco, California, United States
1182.70.020 — San Francisco, California, United States
1182.70.048 — San Francisco, California, United States
1182.70.085 — San Francisco, California, United States
1182.70.214 — San Francisco, California, United States
1182.70.022 — San Rafael, California, United States
1182.70.222 — Stanford, California, United States
1182.70.005 — Tarzana, California, United States
1182.70.030 — Tarzana, California, United States
1182.70.043 — Fountain Valley, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.